Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA delays decision on Lilly and Incyte's arthritis drug
FDA delays decision on Lilly and Incyte's arthritis drug
FDA delays decision on Lilly and Incyte's arthritis drug
Submitted by
admin
on January 17, 2017 - 11:04am
Source:
BioPharma Dive
News Tags:
FDA
Eli Lilly
Incyte
rheumatoid arthritis
baricitinib
Headline:
FDA delays decision on Lilly and Incyte's arthritis drug
Do Not Allow Advertisers to Use My Personal information
